| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1393 | 2019 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 OA Cornely, S Arikan‐Akdagli, E Dannaoui, AH Groll, K Lagrou, ... Clinical Microbiology and Infection 20, 5-26, 2014 | 728 | 2014 |
| A global analysis of mucormycosis in France: the RetroZygo Study (2005–2007) F Lanternier, E Dannaoui, G Morizot, C Elie, D Garcia-Hermoso, M Huerre, ... Clinical Infectious Diseases 54 (suppl_1), S35-S43, 2012 | 558 | 2012 |
| Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006 D Bitar, D Van Cauteren, F Lanternier, E Dannaoui, D Che, F Dromer, ... Emerging infectious diseases 15 (9), 1395, 2009 | 481 | 2009 |
| EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts: Subcommittee on Antifungal Susceptibility … JL Rodriguez-Tudela, MC Arendrup, F Barchiesi, J Bille, E Chryssanthou, ... Clinical Microbiology and Infection 14 (4), 398-405, 2008 | 470 | 2008 |
| ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others AM Tortorano, M Richardson, E Roilides, A Van Diepeningen, M Caira, ... Clinical Microbiology and Infection 20, 27-46, 2014 | 469 | 2014 |
| Sequence-Based Identification of Aspergillus, Fusarium, and Mucorales Species in the Clinical Mycology Laboratory: Where Are We and Where Should We Go … SA Balajee, AM Borman, ME Brandt, J Cano, M Cuenca-Estrella, ... Journal of clinical microbiology 47 (4), 877-884, 2009 | 415 | 2009 |
| Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus JWM Van der Linden, MC Arendrup, A Warris, K Lagrou, H Pelloux, ... Emerging infectious diseases 21 (6), 1041, 2015 | 380 | 2015 |
| Invasive fungal diseases during COVID-19: we should be prepared JP Gangneux, ME Bougnoux, E Dannaoui, M Cornet, JR Zahar Journal de mycologie medicale 30 (2), 100971, 2020 | 375 | 2020 |
| In vitro susceptibilities of zygomycetes to conventional and new antifungals E Dannaoui, J Meletiadis, JW Mouton, JFGM Meis, PE Verweij Journal of Antimicrobial Chemotherapy 51 (1), 45-52, 2003 | 361 | 2003 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi A Chowdhary, JF Meis, J Guarro, GS De Hoog, S Kathuria, MC Arendrup, ... Clinical Microbiology and Infection 20, 47-75, 2014 | 317 | 2014 |
| Healthcare-associated mucormycosis B Rammaert, F Lanternier, JR Zahar, E Dannaoui, ME Bougnoux, ... Clinical Infectious Diseases 54 (suppl_1), S44-S54, 2012 | 311 | 2012 |
| Molecular identification of zygomycetes from culture and experimentally infected tissues P Schwarz, S Bretagne, JC Gantier, D Garcia-Hermoso, O Lortholary, ... Journal of Clinical Microbiology 44 (2), 340-349, 2006 | 234 | 2006 |
| Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? A Espinel-Ingroff, MC Arendrup, MA Pfaller, LX Bonfietti, B Bustamante, ... Antimicrobial agents and chemotherapy 57 (12), 5836-5842, 2013 | 232 | 2013 |
| Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study JP Gangneux, E Dannaoui, A Fekkar, CE Luyt, F Botterel, N De Prost, ... The Lancet Respiratory Medicine 10 (2), 180-190, 2022 | 206 | 2022 |
| Activity of posaconazole in treatment of experimental disseminated zygomycosis E Dannaoui, JFGM Meis, D Loebenberg, PE Verweij Antimicrobial agents and chemotherapy 47 (11), 3647-3650, 2003 | 203 | 2003 |
| Acquired resistance to echinocandins in Candida albicans: case report and review MT Baixench, N Aoun, M Desnos-Ollivier, D Garcia-Hermoso, S Bretagne, ... Journal of antimicrobial chemotherapy 59 (6), 1076-1083, 2007 | 198 | 2007 |
| Acquired itraconazole resistance in Aspergillus fumigatus E Dannaoui, E Borel, MF Monier, MA Piens, S Picot, F Persat Journal of Antimicrobial Chemotherapy 47 (3), 333-340, 2001 | 190 | 2001 |
| Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis F Lanternier, S Poiree, C Elie, D Garcia-Hermoso, P Bakouboula, ... Journal of Antimicrobial Chemotherapy 70 (11), 3116-3123, 2015 | 168 | 2015 |
| Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales RG Vitale, GS De Hoog, P Schwarz, E Dannaoui, S Deng, M Machouart, ... Journal of clinical microbiology 50 (1), 66-75, 2012 | 162 | 2012 |
